Table 6.
Author | Study design | Number of patients (n) | EHBD approach success % (n) | IHBD approach success % (n) | Overall technical success % (n) | Overall clinical success % (n) | Adverse events % (n) |
---|---|---|---|---|---|---|---|
Kahaleh et al. (2006)[59] | Retrospective, single center | 23 | 70 (7/10) | 85 (11/13) | 78 (18/23) | 100 (18/18) | 17 (4/23) |
Dhir et al. (2012)[56] | Retrospective, single center | 58 | 98 (57/58) | - | 98.3 (57/58) | - | 3.4 (2/58) |
Iwashita et al. (2012)[60] | Retrospective, single center | 40 | 81 (25/31) | 44 (4/9) | 72.5 (29/40) | - | 13 (5/40) |
Khashab et al. (2013)[57] | Retrospective, two center | 13 | 100 (11/11) | 100 (2/2) | 100 (13/13) | 100 (13/13) | 15.4 (2/13) |
Dhir et al. (2013)[58] | Retrospective, single center | 35 | 100 (18/18) | 94 (16/17) | 97 (34/35) | - | 23 (8/35) |
Iwashita et al. (2016)[61] | Prospective, multi center | 20 | 80 (16/20) | - | 80 (16/20) | - | 15 (3/20) |
EHBD: Extrahepatic bile duct; IHBD: Intrahepatic bile duct